Professional Documents
Culture Documents
Group 2
Group 2
Patient's history
ABO/Rh typing HLA Typing
Recipient
O, Rh+ A3/A11, B5/B35/B51(5), Bw4/Bw6, Cw1/Cw4, DR1 DQ1/DQ5
Negative Negative
Negative
Patient's history
Rejection of organs with Patients have been treated with dialysis for a while.
Chronic vascular Rejection
Temperature 38.8 °C
2
BMI 36.5 Kg/m
Patient's history 3
nd
2 Donor Pre-transplantation
Post-transplantation
nd
Recipient 2 donor
ABO/Rh typing : O, Rh+ ABO/Rh typing : O, Rh+
The urine volume in the first 3 hours remained
normal and began to decrease.
HLA Typing : T-lymphocyte crossmatch : negative
• A2
Cold, headache, muscle pain, nausea and
vomiting (CDC)
• B44(12)/B60(49)
• Cw3/Cw5 Renal arteries and blood circulating are normal
B-lymphocyte crossmatch : negative
• DR1/DR3/DR9/DR13 DQ2/DQ6
but the patient hasacute renal failure and acute (AHG-CDC)
organ rejection.
T-lymphocyte crossmatch : negative Bead-based Panel Reactive Antibody : negative
(CDC) (PRA)
LO 01
5
Chronic Rejection
Chronic kidney transplant rejection (CKTR)
renal graft function that starts to manifest at one-year after the transplantation and
nonadherence
While Persistent allogeneic immune response remains a major cause multiple risk
factors, e.g. early ischemia reperfusion injury, acute rejection episodes and
of CKTR.
6
http://perspectivesinmedicine.cshlp.org/content/3/11/a015461.full https://jasn.asnjournals.org/content/12/3/574/F3
Antibodies can also bind to the surface molecules of target cells and recruit other
Hyperacute Rejection
Hyperacute rejection is the result of specific recurrent antidonor
antibodies against human leukocyte antigen (HLA), ABO, or other
antigens. Irreversible rapid destruction of the graft occurs.
Histologically there is glomerular thrombosis, fibrinoid necrosis,
and polymorphonuclear leukocyte infiltration.
8
• In hyperacute rejection
preformed antibodies react with alloantigens on the vascular endothelium of the graft, activate
complement, and trigger rapid intravascular thrombosis and necrosis of the vessel wall
9
LO 02
investigation of transplantation
10
https://www.intechopen.com/chapters/42879
Gold standard
https://www.sciencedirect.com/science/article/pii/B9780123694287000306
https://www.researchgate.net/figure/HLA-typing-strategy-The-primer-design-
captures-full-length-HLA-class-I-genes-HLA-A-B_fig1_309596086
12
https://www.intechopen.com/chapters/42879
13
https://www.intechopen.com/chapters/42879
https://www.intechopen.com/chapters/42879
Sensitive with high degree of specific to donor antigen, luminescent more sensitive
than ELISA
Capable of quantifying anti-HLA antibodies level
14
LO 03
https://www.researchgate.net/figure/The-direct-and-indirect-pathways-of-rejection-Recipient-CD4-T-cells-recognize-peptides_fig1_236277505
16
Chronic Rejection
https://flore.unifi.it/retrieve/handle/2158/599069/18128/tesi%20Mariangela%20Sottili.pdf
17
Anti-HLA-A32
18
New tissues/ organs The patient will feel There may be pain, swelling in the Symptoms that depend on
will be malfunctioning physically uncomfortable location of new tissue/ organ. the type of new tissue/ organ.
19
References
Lechler RI, Sykes M, Thomson AW, Turka LA. Organ transplantation: how much of the promise
has been realized Nat Med 2005; 11:605-13.
Hao wang. (2021). Tackling Chronic Kidney Transplant Rejection: Challenges and
Promises. Retrieved November 20,2022, from
https://www.frontiersin.org/articles/10.3389/fimmu.2021.661643/full